WebFeb 10, 2024 · February 10, 2024—CereVasc, Inc. announced that the first patient has been treated in a study of the company’s eShunt system, an investigational device … WebAug 15, 2024 · The eShunt® System includes a proprietary eShunt® Delivery System and the eShunt® Implant, a permanent implant that is deployed in a mildly invasive, neuro …
CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System
WebDec 22, 2024 · The eShunt® System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt … WebFeb 10, 2024 · February 10, 2024—CereVasc, Inc. announced that the first patient has been treated in a study of the company’s eShunt system, an investigational device intended to treat communicating hydrocephalus (CH). Study data will be available in 2024. According to the company, the eShunt system offers a minimally invasive treatment for CH. dhs sci it security awareness training
CereVasc Begins Trial of eShunt System for ... - Endovascular Today
WebAug 18, 2024 · CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System. On August 09, 2024, CereVasc, Inc., a privately held, clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved an … WebAug 29, 2024 · The study, 'US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus (NPH)', is being conducted under an investigational device exemption (IDE) approved by the US Food and ... WebeShunt™ System About Cerevasc CereVasc Neurological Disease Device Company Communicating Hydrocephalus Communicating hydrocephalus results from the impaired absorption of cerebrospinal fluid (CSF) from the intracranial subarachnoid space into the … The innovative nature of the eShunt System highlights a significant opportunity to … Practice guideline: Idiopathic normal pressure hydrocephalus: Response to … Follow-On Products: As a result of the eShunt System development process, … CereVasc, LLC Receives Approval to Initiate First-in-Human Clinical Study of … cincinnati police officer injured